Genes and Age Determine Susceptibility to Lyme Disease
By LabMedica International staff writers Posted on 16 Nov 2016 |
Image: A photomicrograph of Borrelia burgdorferi, the causative pathogen of Lyme disease using dark field microscopy (Photo courtesy of Dr. Jeffrey Nelson, MD).
Despite the importance of immune variation for the symptoms and outcome of Lyme disease, the factors influencing cytokine production during infection with the causal pathogen Borrelia burgdorferi remain poorly understood.
People react very differently to an infection with the Borrelia bacterium that causes Lyme disease, however, despite the large differences observed; the bacterium has a clear effect on the immune system’s energy regulation, opening up opportunities for studies into better detection of Borrelia infections.
An international team of scientists led by those at Radboud University Medical Center (Nijmegen, the Netherlands) investigated how differences in cytokine production during a Borrelia infection in 500 healthy volunteers can be explained. Borrelia infection-induced monocyte- and T cell-derived cytokines were profiled in peripheral blood from two healthy human cohorts of Western Europeans from the Human Functional Genomics Project. Both non-genetic and genetic host factors were found to influence Borrelia-induced cytokine responses.
The team found that the immune response to Lyme disease appears to be strongly age-related. Production of the cytokine interleukin-22 (IL-22) deceases with age, reducing the immune system's defense against the Borrelia bacteria. They also found a genetic variation that increases production of the hypoxia-inducible factor 1-alpha (HIF-1a) protein during a Borrelia infection. This protein causes the amount of lactic acid in the cell to increase, which normally only happens at low oxygen levels. This results in an energy deficiency in the immune cells and therefore a reduction in the production of IL-22 and other inflammatory proteins.
One million people are bitten by a tick in the Netherlands each year, and about one in five of these ticks are carriers of the Borrelia bacterium. The symptoms after an infection vary widely: for example, many people have a red ring or patch around the bite, but some do not. This can make it difficult to give a correct diagnosis. Leo A B Joosten, PhD, a professor of Pathobiology and senior author of the study, said, “We had expected that people with Borrelia antibodies in their blood would have a stronger immune response to the Borrelia bacteria. However, that is not the case. It seems that the Borrelia bacterium does not cause improved resistance.” The study was published on November 3, 2016, in the journal Cell Host & Microbe.
Related Links:
Radboud University Medical Center
People react very differently to an infection with the Borrelia bacterium that causes Lyme disease, however, despite the large differences observed; the bacterium has a clear effect on the immune system’s energy regulation, opening up opportunities for studies into better detection of Borrelia infections.
An international team of scientists led by those at Radboud University Medical Center (Nijmegen, the Netherlands) investigated how differences in cytokine production during a Borrelia infection in 500 healthy volunteers can be explained. Borrelia infection-induced monocyte- and T cell-derived cytokines were profiled in peripheral blood from two healthy human cohorts of Western Europeans from the Human Functional Genomics Project. Both non-genetic and genetic host factors were found to influence Borrelia-induced cytokine responses.
The team found that the immune response to Lyme disease appears to be strongly age-related. Production of the cytokine interleukin-22 (IL-22) deceases with age, reducing the immune system's defense against the Borrelia bacteria. They also found a genetic variation that increases production of the hypoxia-inducible factor 1-alpha (HIF-1a) protein during a Borrelia infection. This protein causes the amount of lactic acid in the cell to increase, which normally only happens at low oxygen levels. This results in an energy deficiency in the immune cells and therefore a reduction in the production of IL-22 and other inflammatory proteins.
One million people are bitten by a tick in the Netherlands each year, and about one in five of these ticks are carriers of the Borrelia bacterium. The symptoms after an infection vary widely: for example, many people have a red ring or patch around the bite, but some do not. This can make it difficult to give a correct diagnosis. Leo A B Joosten, PhD, a professor of Pathobiology and senior author of the study, said, “We had expected that people with Borrelia antibodies in their blood would have a stronger immune response to the Borrelia bacteria. However, that is not the case. It seems that the Borrelia bacterium does not cause improved resistance.” The study was published on November 3, 2016, in the journal Cell Host & Microbe.
Related Links:
Radboud University Medical Center
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms